Literature DB >> 15896809

Neurofilament phosphoforms: surrogate markers for axonal injury, degeneration and loss.

Axel Petzold1.   

Abstract

This review on the role of neurofilaments as surrogate markers for axonal degeneration in neurological diseases provides a brief background to protein synthesis, assembly, function and degeneration. Methodological techniques for quantification are described and a protein nomenclature is proposed. The relevance for recognising anti-neurofilament autoantibodies is noted. Pathological implications are discussed in view of immunocytochemical, cell-culture and genetic findings. With reference to the present symposium on multiple sclerosis, the current literature on body fluid levels of neurofilaments in demyelinating disease is summarised.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15896809     DOI: 10.1016/j.jns.2005.03.015

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  187 in total

1.  Glutamate excitotoxicity is involved in the induction of paralysis in mice after infection by a human coronavirus with a single point mutation in its spike protein.

Authors:  Elodie Brison; Hélène Jacomy; Marc Desforges; Pierre J Talbot
Journal:  J Virol       Date:  2011-09-28       Impact factor: 5.103

2.  Diagnostic and Prognostic Biomarkers in Amyotrophic Lateral Sclerosis: Neurofilament Light Chain Levels in Definite Subtypes of Disease.

Authors:  Alessandra Gaiani; Ilaria Martinelli; Luca Bello; Giorgia Querin; Marco Puthenparampil; Susanna Ruggero; Elisabetta Toffanin; Annachiara Cagnin; Chiara Briani; Elena Pegoraro; Gianni Sorarù
Journal:  JAMA Neurol       Date:  2017-05-01       Impact factor: 18.302

3.  Neurofilament relates to white matter microstructure in older adults.

Authors:  Elizabeth E Moore; Timothy J Hohman; Faizan S Badami; Kimberly R Pechman; Katie E Osborn; Lealani Mae Y Acosta; Susan P Bell; Michelle A Babicz; Katherine A Gifford; Adam W Anderson; Lee E Goldstein; Kaj Blennow; Henrik Zetterberg; Angela L Jefferson
Journal:  Neurobiol Aging       Date:  2018-06-28       Impact factor: 4.673

4.  Protein biomarkers for traumatic and ischemic brain injury: from bench to bedside.

Authors:  Zhiqun Zhang; Stefania Mondello; Firas Kobeissy; Richard Rubenstein; Jackson Streeter; Ronald L Hayes; Kevin K W Wang
Journal:  Transl Stroke Res       Date:  2011-12-07       Impact factor: 6.829

5.  An increase in tolerogenic dendritic cell and natural regulatory T cell numbers during experimental autoimmune encephalomyelitis in Rras-/- mice results in attenuated disease.

Authors:  Avijit Ray; Sreemanti Basu; Nichole M Miller; Andrew M Chan; Bonnie N Dittel
Journal:  J Immunol       Date:  2014-04-25       Impact factor: 5.422

Review 6.  Cytoskeleton as a potential target in the neuropathology of maple syrup urine disease: insight from animal studies.

Authors:  R Pessoa-Pureur; M Wajner
Journal:  J Inherit Metab Dis       Date:  2007-06-14       Impact factor: 4.982

7.  Therapy development for diffuse axonal injury.

Authors:  Douglas H Smith; Ramona Hicks; John T Povlishock
Journal:  J Neurotrauma       Date:  2013-02-14       Impact factor: 5.269

8.  Biomarker evidence for mild central nervous system injury after surgically-induced circulation arrest.

Authors:  Robert Siman; Victoria L Roberts; Elizabeth McNeil; Antony Dang; Joseph E Bavaria; Sindhu Ramchandren; Michael McGarvey
Journal:  Brain Res       Date:  2008-04-01       Impact factor: 3.252

9.  A novel biomarker for retinal degeneration: vitreous body neurofilament proteins.

Authors:  Axel Petzold; Anselm Junemann; Konrad Rejdak; Tomasz Zarnowski; Sebastian Thaler; Pawel Grieb; Friedrich E Kruse; Eberhart Zrenner; Robert Rejdak
Journal:  J Neural Transm (Vienna)       Date:  2009-09-22       Impact factor: 3.575

10.  Oligodendrocyte loss during the disease course in a canine model of the lysosomal storage disease fucosidosis.

Authors:  Jessica L Fletcher; Gauthami S Kondagari; Charles H Vite; Peter Williamson; Rosanne M Taylor
Journal:  J Neuropathol Exp Neurol       Date:  2014-06       Impact factor: 3.685

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.